Radio and PodcastRadio and PodcastLive Radio & Podcasts
Rapid Whole-Genome Sequencing as a First-Line Test Is Likely to Significantly Reduce the Cost of Acute Care in a Private Payer System artwork
Science & Medicine

Rapid Whole-Genome Sequencing as a First-Line Test Is Likely to Significantly Reduce the Cost of Acute Care in a Private Payer System

JALM Talk Podcast by American Association for Clinical Chemistry

Jul 24, 202511:13Science & Medicine

Rapid Whole-Genome Sequencing as a First-Line Test Is Likely to Significantly Reduce the Cost of Acute Care in a Private Payer System - JALM Talk Podcast

Related Episodes

Continue listening to more episodes from JALM Talk Podcast.